A transformation is underway in medical coding as automation permeates revenue cycle management, raising questions such as: How will automation affect how medical coders work? How advanced is coding automation currently? What kind of skill sets will be needed for these new types of coding?
Healthcare staffing shortages are leading to negative patient experiences, which is especially troublesome for small healthcare practices that often use good patient experiences to differentiate themselves from competitors, according to a new report. To address this trend, healthcare clinics should regularly meet to assess the patient experience at their practice as well as staff pain points that can be alleviated through automation technology.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Healthcare, like much of the rest of the economy, is facing a labor shortage. Artificial intelligence can lighten the load for overworked providers through everything from automation to triaging patients.
Offloading menial tasks to digital assistants isn’t just about a reduction in workload; it allows physicians to refocus their time on what they entered the profession to do—treating patients.
Dental payers can no longer rely on the processes, methodologies and technologies of the past. They must adopt new technologies, like automation, that deliver the level of performance required to compete in today’s digital world.
Hospital leaders must meet or exceed patients' expectations for a pleasant, predictable registration experience to maintain a competitive advantage. Consumers don’t see how real-time patient tracking helps departments communicate better, but it has an outsized effect on their experience.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Specialty drugs represent a growing share of overall pharmaceutical sales, and Omnicell is acquiring specialty pharmacy technologies company ReCept Pharmacy to enter this market. Omnicell is paying $100 million cash to buy ReCept.
The deadline to comply with the No Surprises - January 1 - is practically around the corner. Payers that want to be in compliance with its provider directory provision must act now.
The company's data processing platform can help payers comply with the law banning surprise billing, which requires insurers to process all provider directory updates in less than two days starting in 2022.
The company will use the funds to develop new solutions and tools that can identify and correct anomalies in providers' revenue cycle processes and automate repetitive tasks.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Innovation Lab, an incubator owned by six nonprofit health systems, is joining forces with Olive to co-develop technology that will automate operational and clinical workflows. The companies will leverage Olive's AI platform, as well as Innovation Lab's frontline access to its health system owners.
These innovations have not only made medical check-ups safer, but they’ve also helped modernize and improve the patient journey. These technologies automated many archaic administrative functions and offered medical practices genuine savings - in terms of both time and money.
Though telehealth will continue to account for a large portion of healthcare IT budgets in 2021, there are other technology-based services driving provider interest. These range from cloud deployment to vaccine scheduling solutions as providers navigate the new landscape created by the Covid-19 pandemic.
A vaccine communication playbook developed by WELL™ Health offers guidance to providers on how to meet the communication challenges to ensure patients get both doses of the Covid-19 vaccine.
General Catalyst, which invested in Olive earlier this spring, led the funding round. Existing investor Drive Capital also co-led the round.